Association Study of OPRM1 Gene in a Sample of Schizophrenia Patients With Alcohol Dependence or Abuse

2019 ◽  
Vol 10 (4) ◽  
pp. 30-34
Author(s):  
Marie N.S. Gendy ◽  
Clement Zai ◽  
Bernard Le Foll ◽  
James L. Kennedy
2021 ◽  
pp. 026988112199199 ◽  
Author(s):  
Miriam Sebold ◽  
Maria Garbusow ◽  
Deniz Cerci ◽  
Ke Chen ◽  
Christian Sommer ◽  
...  

Background: Pavlovian-to-instrumental transfer (PIT) quantifies the extent to which a stimulus that has been associated with reward or punishment alters operant behaviour. In alcohol dependence (AD), the PIT effect serves as a paradigmatic model of cue-induced relapse. Preclinical studies have suggested a critical role of the opioid system in modulating Pavlovian–instrumental interactions. The A118G polymorphism of the OPRM1 gene affects opioid receptor availability and function. Furthermore, this polymorphism interacts with cue-induced approach behaviour and is a potential biomarker for pharmacological treatment response in AD. In this study, we tested whether the OPRM1 polymorphism is associated with the PIT effect and relapse in AD. Methods: Using a PIT task, we examined three independent samples: young healthy subjects ( N = 161), detoxified alcohol-dependent patients ( N = 186) and age-matched healthy controls ( N = 105). We used data from a larger study designed to assess the role of learning mechanisms in the development and maintenance of AD. Subjects were genotyped for the A118G (rs1799971) polymorphism of the OPRM1 gene. Relapse was assessed after three months. Results: In all three samples, participants with the minor OPRM1 G-Allele (G+ carriers) showed increased expression of the PIT effect in the absence of learning differences. Relapse was not associated with the OPRM1 polymorphism. Instead, G+ carriers displaying increased PIT effects were particularly prone to relapse. Conclusion: These results support a role for the opioid system in incentive salience motivation. Furthermore, they inform a mechanistic model of aberrant salience processing and are in line with the pharmacological potential of opioid receptor targets in the treatment of AD.


2015 ◽  
Vol 22 (2) ◽  
pp. 535-549 ◽  
Author(s):  
Renato Polimanti ◽  
Huiping Zhang ◽  
Andrew H. Smith ◽  
Hongyu Zhao ◽  
Lindsay A. Farrer ◽  
...  

2015 ◽  
Vol 39 (2) ◽  
pp. 205-211 ◽  
Author(s):  
Any Carolina C. G. Vasconcelos ◽  
Edmilson de Souza R. Neto ◽  
Giovanny R. Pinto ◽  
France Keiko N. Yoshioka ◽  
Fábio José N. Motta ◽  
...  

2017 ◽  
Vol 41 (5) ◽  
pp. 911-928 ◽  
Author(s):  
Amy E. Adkins ◽  
Laura M. Hack ◽  
Tim B. Bigdeli ◽  
Vernell S. Williamson ◽  
G. Omari McMichael ◽  
...  

2009 ◽  
Vol 33 (12) ◽  
pp. 2147-2153 ◽  
Author(s):  
Pilar A. Saiz ◽  
Maria P. Garcia-Portilla ◽  
Gerardo Florez ◽  
Paul Corcoran ◽  
Celso Arango ◽  
...  

2010 ◽  
Vol 14 (03) ◽  
pp. 377-388 ◽  
Author(s):  
Gordana Nedic ◽  
Matea Nikolac ◽  
Korona Nenadic Sviglin ◽  
Dorotea Muck-Seler ◽  
Fran Borovecki ◽  
...  

2013 ◽  
Vol 38 (2) ◽  
pp. 545-550
Author(s):  
Jason Yongha Kim ◽  
Joon Seol Bae ◽  
Byung Lae Park ◽  
Jeong-Hyun Kim ◽  
Lyoung Hyo Kim ◽  
...  

2011 ◽  
Vol 16 (2) ◽  
pp. 323-333 ◽  
Author(s):  
Ulrich W. Preuss ◽  
Monika Ridinger ◽  
Dan Rujescu ◽  
Jerzy Samochowiec ◽  
Christoph Fehr ◽  
...  

2019 ◽  
Vol 29 ◽  
pp. S971
Author(s):  
Hang Zhou ◽  
Renato Polimanti ◽  
Bao-Zhu Yang ◽  
Qian Wang ◽  
Shizhong Han ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document